Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher E Rudd

Showing results (11-20 of 120) with videos related to

Pageof 12
Sort By:
Nature Reviews. Immunology|January 26, 2008
The reverse stop-signal model for CTLA4 functionChristopher E Rudd
Nature Immunology|October 21, 2006
Cell cycle 'check points' T cell anergyChristopher E Rudd
Frontiers in Immunology|July 23, 2020
GSK-3 Inhibition as a Therapeutic Approach Against SARs CoV2: Dual Benefit of Inhibiting Viral Replication While Potentiating the Immune ResponseChristopher E Rudd
Nature Reviews. Immunology|July 24, 2003
Unifying concepts in CD28, ICOS and CTLA4 co-receptor signallingChristopher E Rudd, Helga Schneider
Plos Biology|May 19, 2021
Programmed cell death 1 ligand (PD-L1) on T cells generates Treg suppression from memoryAlexandra Kazanova, Christopher E Rudd
British Journal of Haematology|February 14, 2002
Signalling scaffolds and adaptors in T-cell immunityLiping Geng, Christopher E Rudd
BMC Research Notes|March 20, 2020
Glycogen synthase kinase 3 (GSK-3) controls T-cell motility and interactions with antigen presenting cellsAlison Taylor, Christopher E Rudd
Self/Nonself|April 14, 2011
CD28 co-signaling in the adaptive immune responsePavel Riha, Christopher E Rudd
Immunological Reviews|April 3, 2003
Independent CD28 signaling via VAV and SLP-76: a model for in trans costimulationChristopher E Rudd, Monika Raab
Immunity|April 20, 2017
Two Strings in One Bow: PD-1 Negatively Regulates via Co-receptor CD28 on T CellsJanna Krueger, Christopher E Rudd
Pageof 12

Showing results (11-20 of 120) with videos related to

Sort By:
Pageof 12
Nature Reviews. Immunology|January 26, 2008
The reverse stop-signal model for CTLA4 functionChristopher E Rudd
Nature Immunology|October 21, 2006
Cell cycle 'check points' T cell anergyChristopher E Rudd
Frontiers in Immunology|July 23, 2020
GSK-3 Inhibition as a Therapeutic Approach Against SARs CoV2: Dual Benefit of Inhibiting Viral Replication While Potentiating the Immune ResponseChristopher E Rudd
Nature Reviews. Immunology|July 24, 2003
Unifying concepts in CD28, ICOS and CTLA4 co-receptor signallingChristopher E Rudd, Helga Schneider
Plos Biology|May 19, 2021
Programmed cell death 1 ligand (PD-L1) on T cells generates Treg suppression from memoryAlexandra Kazanova, Christopher E Rudd
British Journal of Haematology|February 14, 2002
Signalling scaffolds and adaptors in T-cell immunityLiping Geng, Christopher E Rudd
BMC Research Notes|March 20, 2020
Glycogen synthase kinase 3 (GSK-3) controls T-cell motility and interactions with antigen presenting cellsAlison Taylor, Christopher E Rudd
Self/Nonself|April 14, 2011
CD28 co-signaling in the adaptive immune responsePavel Riha, Christopher E Rudd
Immunological Reviews|April 3, 2003
Independent CD28 signaling via VAV and SLP-76: a model for in trans costimulationChristopher E Rudd, Monika Raab
Immunity|April 20, 2017
Two Strings in One Bow: PD-1 Negatively Regulates via Co-receptor CD28 on T CellsJanna Krueger, Christopher E Rudd
Pageof 12